Russell Investments Group
CRDF icon

Russell Investments Group’s Cardiff Oncology CRDF Stock Holding History

Russell Investments Group’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-5,135
Closed -$8.32K – 4390
2026
Q1 		$8.32K Hold
5,135
– – ﹤0.01% 3819
2025
Q4 		$14.4K Hold
5,135
– – ﹤0.01% 3706
2025
Q3 		$10.6K Buy
+5,135
New +$14.2K ﹤0.01% 3781
2021
Q4 		– Sell
-3,898
Closed -$25K – 3011
2021
Q3 		$25K Sell
3,898
-1,534
-28% -$9.64K ﹤0.01% 2985
2021
Q2 		$36K Buy
+5,432
New +$46.1K ﹤0.01% 3154

Other funds holding CRDF

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AC
Avestar Capital New York $1.79B AUM 33.8% 1-Year Est. Return
AC
AlphaCore Capital La Jolla, California $5.44B AUM 26.35% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

Russell Investments Group's CRDF Position: Q2 2026 in Review

Russell Investments Group sold out of Cardiff Oncology (CRDF) in Q2 2026, closing a stake of 5,135 shares — an estimated $8.32K sold.

Russell Investments Group first reported a position in CRDF in Q2 2021 and held it in 5 quarters. The position peaked at $36K in Q2 2021. 43 funds tracked by Wall St. Rank hold CRDF as of Q2 2026.

  • Russell Investments Group reported no remaining Cardiff Oncology position as of Q2 2026 after selling out during the quarter.
  • Russell Investments Group sold 5,135 Cardiff Oncology shares in Q2 2026, an estimated $8.32K.
  • Russell Investments Group first reported a position in Cardiff Oncology in Q2 2021 and held it in 5 quarters.
  • Russell Investments Group's Cardiff Oncology position peaked at $36K in Q2 2021.
  • 43 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.